BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement-March 2024-www.financetom.com

BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement

Nov 3, 2024 3:31 PM

Oct 31 (Reuters) - Aerovate Therapeutics Inc ( AVTE ):

* AEROVATE THERAPEUTICS AND JADE BIOSCIENCES ANNOUNCE MERGER

AGREEMENT

* AEROVATE THERAPEUTICS INC ( AVTE ) - JADE SECURES $300 MILLION IN

PRIVATE

INVESTMENT

* AEROVATE THERAPEUTICS INC ( AVTE ) - STOCKHOLDERS TO OWN 1.6% OF

COMBINED

COMPANY

* AEROVATE THERAPEUTICS INC ( AVTE ) - TOM FROHLICH TO LEAD COMBINED

COMPANY AS CEO

* AEROVATE THERAPEUTICS INC ( AVTE ) - TO DECLARE $65 MILLION CASH

DIVIDEND

TO STOCKHOLDERS

Source text:

Further company coverage:

Previous page： Franco-Nevada Q3 Adjusted Net Income, Revenue Increases Next page： Grab Holdings beats quarterly revenue estimates

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Franco-Nevada Q3 Adjusted Net Income, Revenue Increases

Nov 3, 2025

05:53 PM EST, 11/03/2025 (MT Newswires) -- Franco-Nevada ( FNV ) reported Q3 adjusted net income late Monday of $1.43 per share, up from $0.80 a year earlier. Analysts polled by FactSet expected $1.38 per share. Revenue for the quarter ended Sept. 30 was $487.7 million, up from $275.7 million a year earlier. Analysts polled by FactSet expected $464.5 million....

Grab Holdings beats quarterly revenue estimates

Nov 3, 2025

Nov 3 (Reuters) - Grab Holdings ( GRAB ) beat analysts' expectations for third-quarter revenue on Monday, helped by robust consumer spending on its ride-hailing and food-delivery services as its platform expansion draws in more users. The company reported revenue of $873 million during the period, compared with analysts' average estimate of $872.9 million, according to data compiled by LSEG....

ZoomInfo Technologies Q3 Adjusted Earnings Unchanged, Revenue Rises; Shares Gain After Hours

Nov 3, 2025

05:49 PM EST, 11/03/2025 (MT Newswires) -- ZoomInfo Technologies ( GTM ) reported Q3 adjusted earnings late Monday of $0.28 per diluted share, flat from $0.28 per share a year earlier. Analysts polled by FactSet expected $0.26 per share. Revenue in the three months ended Sept. 30 rose to $318 million from $303.6 million a year earlier. Analysts surveyed by...

Dream Impact Trust posts Q3 net loss of C$10.3 million

Nov 3, 2025

Overview * Dream Impact Trust Q3 net loss C$10.3 mln, missing analyst expectations * Company's rental assets occupancy exceeds 90%, up 15% since June 2025 * Trust secured $15 mln loan from Dream, extended Fairfax debentures to 2031 Outlook * Dream Impact Trust expects stabilized rental assets to boost earnings over the next year * Company plans to commence development...